Medical Imaging Technologies for Oncology Diagnostics: The Global Market

• Publication date: March 2011

Review technologies such as computed tomography (CT), dual-slice and multi-slice tomography, positron emission tomography (PET), positron emission mammography (PEM), digital X-rays, single photon emission computed tomography (SPECT), full-body MRIs, gamma cameras, and 2-D and 3-D ultrasounds Provide global market data for 2002, 2006, and 2008, with estimates for 2009, and compound annual growth rate (CAGR) projections through 20...

Review technologies such as computed tomography (CT), dual-slice and multi-slice tomography, positron emission tomography (PET), positron emission mammography (PEM), digital X-rays, single photon emission computed tomography (SPECT), full-body MRIs, gamma cameras, and 2-D and 3-D ultrasounds

Provide global market data for 2002, 2006, and 2008, with estimates for 2009, and compound annual growth rate (CAGR) projections through 2014

Discuss market drivers for earlier cancer detection and increasing trends of preventive medicine throughout the world

Offer a comprehensive list of company profiles. 
 



INTRODUCTION

STUDY GOALS AND OBJECTIVES

The goal of this study is to report on the size of the global and regional markets for imaging equipment used in the diagnosis of cancer. This includes the markets of 2009 and 2010 and the trends and sales in these markets for 2010 through 2015. Important manufacturers, technologies and factors influencing demand are discussed, including reasons behind the market forecasts, drivers and restraints in each market segment, and current and expected environmental influences on these markets.

The reader of this study will gain a solid overall look at the current market for diagnostic imaging equipment in oncology, and the elements expected to drive the markets during the next 5 years. The reader will be better equipped to create a company strategy that will positively affect business activities and revenue during the next 5 years.

REASONS FOR DOING THE STUDY

Developments in diagnostic imaging are radically changing oncology diagnostic procedures. Due to the breadth and scope of these developments, there are significant opportunities for companies to both design and market new products, and to profitably partner with companies offering complementary equipment. This study discusses where such opportunities lie today, and in what directions future prospects may lie.

SCOPE OF REPORT

Oncology diagnostic imaging products designate hardware, software, and supplies used to create, view, and manage visual images of nonvisible organs of the human body for purposes of diagnosing cancer. The report focuses on end-user markets, including hospitals, freestanding clinics, doctors’ offices, and equipment leasing companies.

The following well-established technologies are included in the study: flat panel display (FPD) products such as computed radiography (CR), x-ray, including analog and digital x-ray; magnetic resonance imaging (MRI), including standard MRI and functional MRI or MR fluoroscopy; computed tomography (CT), including standard CT, multislice or ultrafast CT, and electron beam tomography; single photon emission computed tomography (SPECT); positron emission tomography (PET); ultrasound; and endoscopy, including fiber-optic endoscopy, video endoscopy, and ingestible cameras. In the last few years, several multimodal products have been developed in an attempt to combine the advantages of structural and functional imaging. Multimodal combinations currently on the market include CT/SPECT; PET/CT; MRI/MSI; and endoscopic ultrasound (EUS), combining fiber-optic endoscopy and ultrasound. Nearly 100% of all PET sales today are in the form of combination PET/CT imaging systems; therefore, this report addresses the market for PET/CT oncology diagnostics systems rather than PET standalone systems.

New and emerging technologies that may become commercially significant by 2015 are also addressed in this report. These include contrast-enhanced ultrasound, subharmonic breast ultrasound, whole-breast ultrasound tomography, radiation luminescence and radioactive optical nano-imaging techniques, near-infrared fluorescent imaging, near-infrared (NIR) optical coherence tomography, supersonic shear imaging (SSI), microwave tomography, cone beam CT, digital breast tomosynthesis (DBT), single-shot spectral imaging (SSSI) for mammography, breast-specific gamma imaging (BSGI), and photoacoustic tomography (PT). The latest development in combination imaging is PET/MR, now being introduced by Siemens, Philips, and GE.

Products used for radiotherapy, dentistry, nonmedical imaging (e.g., in physics, chemistry, geology, and industry), and veterinary medicine are excluded from the study.

INTENDED AUDIENCE

This report is intended for industry managers of business development, marketing and engineering; CEOs; venture capital companies; and research and development companies and executives.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this report. Information was acquired from interviews with industry managers and physicians. Information also came from extensive secondary research in medical journals, newsletters, manufacturers’ websites, published news items, and research reports on the Internet.

Global Medical Imaging Industry

CHAPTER ONE: INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

SCOPE OF REPORT

INTENDED AUDIENCE

METHODOLOGY AND INFORMATION SOURCES

ANALYST CREDENTIALS

RELATED REPORTS

BCC ONLINE SERVICES

DISCLAIMER

CHAPTER TWO: SUMMARY

SUMMARY TABLE GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

SUMMARY FIGURE GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, 2009-2015 ($ MILLIONS)

TABLE 1 GLOBAL CANCER INCIDENCE AND PREVALENCE

TABLE 2 MANUFACTURERS OF X-RAY SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 3 MANUFACTURERS OF CT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 4 MANUFACTURERS OF MRI SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 5 MANUFACTURERS OF ULTRASOUND SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 6 MANUFACTURERS OF ENDOSCOPY SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 7 MANUFACTURERS OF PACS SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 8 MANUFACTURERS OF SPECT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 9 MANUFACTURERS OF PET/CT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)

TABLE 10 NUMBER OF INSTALLED SELECT DIAGNOSTIC IMAGING UNITS, BY LOCATION, 2009

TABLE 11 NUMBER OF DIAGNOSTIC RADIOLOGY PROFESSIONALS, BY LOCATION, 2009

TABLE 12 PRICE PER STUDY IN U.S., BY PROCEDURE TYPE, THROUGH 2015 ($)

TABLE 13 HOSPITAL EXPENDITURES ON DIAGNOSTIC IMAGING EQUIPMENT, BY TECHNOLOGY TYPE (U.S.), THROUGH 2015 ($ MILLIONS)

TABLE 14 RECENT U.S. PATENTS FOR DIAGNOSTIC IMAGING

TABLE 15 RECENT PATENT AND PATENT APPLICATIONS FOR DIAGNOSTIC IMAGING

TABLE 18 ONCOLOGY DIAGNOSTIC IMAGING MARKETS, BY APPLICATION, 2009 ($ MILLIONS/%)

FIGURE 1 ONCOLOGY DIAGNOSTIC IMAGING MARKETS, BY APPLICATION, 2009 (%)

SUMMARY

TABLE 19 PERCENTAGE USE IN ONCOLOGY DIAGNOSTICS APPLIED TO EACH MODALITY, 2009 (%)

TABLE 20 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 21 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 (UNITS)

TABLE 22 DIAGNOSTIC IMAGING FOR ONCOLOGY: USER EXPENDITURES, BY GEOGRAPHY, THROUGH 2015 ($ MILLIONS/%)

TABLE 23 U.S. MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 24 CANADA, MEXICO, BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 25 CANADA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 26 MEXICO MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 27 BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 28 EU MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 29 UNITED KINGDOM MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 30 GERMANY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 31 FRANCE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 32 SPAIN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 33 ITALY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 34 REST OF EUROPE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 35 JAPAN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 36 CHINA, INDIA, AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 37 CHINA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 38 INDIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)

TABLE 39 AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)